JACKSONVILLE, NC (WITN) -The past water contamination at Camp Lejeune has been a recurring topic for 40 years. Many lives have been lost, creating a permanent scar on Veterans and families.

“Our servicemen, when they serve our country and give up their time,” said Paul Doolittle, Class Action and Mass Tort Director, “They expect that their families are going to be taken care of.”

According to data, people have developed all kinds of health problems from drinking the toxic water.

Poulin, Willey, and Anastopoulo Law Firm said it wanted to help victims after claiming to have filed the first Camp

NEW YORK, Feb. 15, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Enovix Corporation.

Shareholders who purchased shares of ENVX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/enovix-class-action-submission-form/?id=36520&from=4

PERIOD CLASS: This lawsuit is on behalf of all investors who purchased or otherwise acquired Enovix common stock (or Rodgers Silicon Valley Acquisition Corp. common stock prior to July 15, 2021) between February 22, 2021 and January 3, 2023inclusive.

NEW YORK, Feb. 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you have suffered losses exceeding $100,000 invest in Invivid stock or options between November 29, 2021 and December 14, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partners Josh Wilson

Welcome to the third annual installment of Seyfarth Shaw’s Commercial Litigation Outlook, in which our nationally-recognized team provides insights about litigation issues and trends to expect in 2023.

The likely continuing global tumult and increasing chances for a recession will weigh heavily on the litigation outlook for 2023. In short, we expect an uneven year where some litigation booms and some busts. As was true last year, the trick to navigating the upcoming challenges will require clients and their counsel to be adaptive, creative and proactive.

Join us for a three-part webinar serieswhere members of our Commercial Litigation practice

NEW YORK, NY / ACCESSWIRE / February 2, 2023 /

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tattooed Chef, Inc. TTCF between March 20, 2021 and October 12, 2022, both dates inclusive (the “Class Period”), of the important February 21, 2023 lead plaintiff deadline in the securities class action commenced by the Firm.

SO WHAT: If you purchased Tattooed Chef securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To

Tuesday, January 24, 2023
1:00 pm to 2:00 pm Eastern
12:00 pm to 1:00 pm Central
11:00 am to 12:00 pm Mountain
10:00 am to 11:00 am Pacific

REGISTER HERE

In the second installment of the 2023 Trade Secrets Webinar Series, Seyfarth attorneys will review the noteworthy legislation, cases, and legal developments from across the nation over the last year in the areas of trade secrets and data theft, non-competes and other restrictive covenants , and computer fraud. Plus, they will provide predictions for what to expect in 2023.

Seyfarth attorneys, Michael Wexler, Robert Milligan, and Joshua Salinas will address

NEW YORK, Jan. 16, 2023 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ:NEO) between February 27, 2020 and April 26, 2022both dates inclusive (the “Class Period”), of the important February 6, 2023 lead plaintiff deadline.

SO WHAT: If you purchased NeoGenomics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the NeoGenomics class action, go to https://rosenlegal.com/submit-form/?case_id=4888 or call Philip Kim,